Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Mar-23 4:33 PM View:  | Gower Bob G Director | Ensysce Biosciences, Inc. (LACQ) | 02-Mar-23 | Private Purchase | 90,287 | $0.49 | $44,087.10 | 8% 1.13M to 1.22M | |
| 02-Mar-23 3:45 PM View: | Gower Bob G Director | Ensysce Biosciences, Inc. (LACQ) | 01-Mar-23 | Purchase | 270,000 | $0.48 | $128,979.00 | 31% 862.4K to 1.13M | |
| 02-Mar-23 3:45 PM View: | Gower Bob G Director | Ensysce Biosciences, Inc. (LACQ) | 28-Feb-23 | Private Purchase | 109,300 | $0.49 | $53,371.20 | 15% 753.1K to 862.39K | |
| 01-Feb-23 6:06 PM View: | Gower Bob G Director | Ensysce Biosciences, Inc. (LACQ) | 09-Dec-22 | Private Purchase | 357,143 | $1.40 | $500,000.00 | 90% 395.95K to 753.1K | |
| 27-May-22 2:05 PM View: | Kirkpatrick Lynn Chief Executive Officer Director | Ensysce Biosciences, Inc. (LACQ) | 26-May-22 | Purchase | 27,000 | $0.53 | $14,215.50 | 8% 354.85K to 381.85K | |
| 27-May-22 2:05 PM View: | Kirkpatrick Lynn Chief Executive Officer Director | Ensysce Biosciences, Inc. (LACQ) | 25-May-22 | Private Purchase | 70,000 | $0.49 | $34,083.00 | 25% 284.85K to 354.85K | |
| 02-Jul-21 7:15 PM View: | Humphrey David Carl Chief Financial Officer | Ensysce Biosciences, Inc. (LACQ) | 30-Jun-21 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 02-Jul-21 6:11 PM View: | Kirkpatrick Lynn Chief Executive Officer Director | Ensysce Biosciences, Inc. (LACQ) | 30-Jun-21 | Grant | 284,851 | -- | -- | 100% 0 to 284.85K | |
| 02-Jul-21 7:14 PM View: | Chang William H Director 10% Owner | Ensysce Biosciences, Inc. (LACQ) | 30-Jun-21 | Grant | 353,451 | -- | -- | 100% 0 to 353.45K | |
| 02-Jul-21 6:15 PM View: | Gower Bob G Director | Ensysce Biosciences, Inc. (LACQ) | 30-Jun-21 | Grant | 7,919,030 | -- | -- | 100% 0 to 7.92M | |
| 02-Jul-21 7:14 PM View: | Chang William H Director 10% Owner | Ensysce Biosciences, Inc. (LACQ) | 30-Jun-21 | Grant | 2,242,190 | -- | -- | 634% 353.45K to 2.6M | |
| 23-Jun-20 5:39 PM View: | Morgan Stanley 10% Owner | Ensysce Biosciences, Inc. (LACQ) | 19-Jun-20 | Sale | 776,290 | -- | -- | (100%) 776.29K to 0 | |
| 17-Jan-18 5:26 PM View: | Peng George Chief Financial Officer | Ensysce Biosciences, Inc. (LACQ) | 15-Jan-18 | Disposition (other) | 13,251 | -- | -- | (13%) 100.27K to 87.01K | |
| 17-Jan-18 5:35 PM View: | Weil A Lorne Executive Chairman Director | Ensysce Biosciences, Inc. (LACQ) | 15-Jan-18 | Disposition (other) | 40,645 | -- | -- | (3%) 1.31M to 1.27M | |
| 17-Jan-18 5:18 PM View: | Silvers Daniel B. Chief Executive Officer Director | Ensysce Biosciences, Inc. (LACQ) | 15-Jan-18 | Disposition (other) | 171,832 | -- | -- | (13%) 1.3M to 1.13M | |
| 17-Jan-18 5:21 PM View: | Carrera Eric Senior Vice President | Ensysce Biosciences, Inc. (LACQ) | 15-Jan-18 | Disposition (other) | 8,330 | -- | -- | (13%) 63.03K to 54.7K | |
| 17-Jan-18 5:35 PM View: | Weil A Lorne Executive Chairman Director | Ensysce Biosciences, Inc. (LACQ) | 15-Jan-18 | Disposition (other) | 132,158 | -- | -- | (10%) 1.27M to 1.13M | |
| 17-Jan-18 5:39 PM View: | Hg Vora Capital Management,... 10% Owner | Ensysce Biosciences, Inc. (LACQ) | 15-Jan-18 | Disposition (other) | 375,000 | -- | -- | (10%) 3.84M to 3.46M | |
| 05-Dec-17 6:56 PM View: | Carrera Eric Senior Vice President | Ensysce Biosciences, Inc. (LACQ) | 05-Dec-17 | Disposition (other) | 1,465 | -- | -- | (2%) 64.5K to 63.03K | |
| 05-Dec-17 6:56 PM View: | Hg Vora Capital Management,... 10% Owner | Ensysce Biosciences, Inc. (LACQ) | 05-Dec-17 | Disposition (other) | 718,750 | -- | -- | (20%) 3.56M to 2.84M | |
| 05-Dec-17 6:56 PM View: | Weil A Lorne Executive Chairman Director | Ensysce Biosciences, Inc. (LACQ) | 05-Dec-17 | Disposition (other) | 187,166 | -- | -- | (11%) 1.66M to 1.48M | |
| 05-Dec-17 6:55 PM View: | Peng George Chief Financial Officer | Ensysce Biosciences, Inc. (LACQ) | 05-Dec-17 | Disposition (other) | 733 | -- | -- | (< 1%) 101.0K to 100.27K | |
| 05-Dec-17 6:56 PM View: | Weil A Lorne Executive Chairman Director | Ensysce Biosciences, Inc. (LACQ) | 05-Dec-17 | Disposition (other) | 169,517 | -- | -- | (11%) 1.48M to 1.31M | |
| 05-Dec-17 6:57 PM View: | Silvers Daniel B. Chief Executive Officer Director | Ensysce Biosciences, Inc. (LACQ) | 05-Dec-17 | Disposition (other) | 359,869 | -- | -- | (22%) 1.66M to 1.3M | |
| 17-Jan-18 5:39 PM View: | Hg Vora Capital Management,... 10% Owner | Ensysce Biosciences, Inc. (LACQ) | 01-Dec-17 | Purchase | 1,000,000 | $10.00 | $10,000,000.00 | 35% 2.84M to 3.84M |
